Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Dogs Pfizer Inc Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags LVMH Moet Hennessy Louis Vuitton SE Europe Markets Sanofi SA
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Breaking News: Markets Pharmaceuticals Zealand Pharma A/S
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Prescription drugs Corporate Finance Novo Nordisk A/S
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Roche Holding AG Health care industry Eli Lilly and Co
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Business News Health & Science Biotechnology
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Mergers Eli Lilly and Co Health care industry
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Earnings Health care industry Investment strategy
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Advanced Micro Devices Inc Meta Platforms Inc
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Business News Health & Science Biotechnology
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Terns Pharmaceuticals Inc Pfizer Inc Amgen Inc
From CNBC.com News
People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey
Tags Eli Lilly and Co Compute Health Acquisition Corp Nestle SA
From CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
Tags Prescription drugs Politics Bristol/Myers Squibb Co
From CNBC.com News
Here are the big health sector themes to watch next year
Tags Dexcom Inc Pfizer Inc Novo Nordisk A/S
From CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Pharmaceuticals Business Biogen Inc
From CNBC.com News
5 things to know before the stock market opens Monday
Tags 5 Things to Know Business Economy
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags Roche Holding AG Health care industry Eli Lilly and Co
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Business News Health & Science Biotechnology
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Business Pharmaceuticals Breaking news
From CNBC.com News
An EU wealth tax and the end of U.S. capitalism: One bank’s ‘outrageous’ predictions for 2024
Tags World Economy Investing Breaking News: Economy
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Investing Hormel Foods Corp Business News
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Science Business Pharmaceuticals
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Clinical trials Health care industry Diabetes
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Eli Lilly and Co Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags Investment Strategy Business stocks
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Health care industry Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Walt Disney Co Walmart Inc TJX Companies Inc
From CNBC.com News
Novo Nordisk's weight loss drug Wegovy slashes risk of serious heart events
Tags Social issues Health & Science Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.